Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2017 | 3′UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma | Hua K.-T.; Liu Y.-F.; Hsu C.-L.; Cheng T.-Y.; CHING-YAO YANG ; Chang J.-S.; Lee W.-J.; Hsiao M.; Juan H.-F.; Chien M.-H.; Yang S.-F. | Scientific Reports | 30 | 37 | |
2021 | 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene, a Major Active Metabolite of Bisphenol A, Triggers Pancreatic β-Cell Death via a JNK/AMPKα Activation-Regulated Endoplasmic Reticulum Stress-Mediated Apoptotic Pathway | Huang, Cheng-Chin; CHING-YAO YANG ; Su, Chin-Chuan; Fang, Kai-Min; Yen, Cheng-Chieh; Lin, Ching-Ting; Liu, Jui-Min; Lee, Kuan-I; Chen, Ya-Wen; Liu, Shing-Hwa; Huang, Chun-Fa | International journal of molecular sciences | | 1 | |
2021 | Advanced glycation end products activated endothelial-to-mesenchymal transition in pancreatic islet endothelial cells and triggered islet fibrosis in diabetic mice | Tsai, Pei-Shan; Chiu, Chen-Yuan; Sheu, Meei-Ling; CHING-YAO YANG ; Lan, Kuo-Cheng; Liu, Shing-Hwa | Chemico-biological interactions | 0 | 0 | |
2015 | Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas | Lee J.-C.; Jeng Y.-M.; Liau J.-Y.; Tsai J.-H.; Hsu H.-H.; CHING-YAO YANG | Modern Pathology | 30 | 33 | |
2015 | Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas | Liau J.-Y.; Tsai J.-H.; CHING-YAO YANG ; Lee J.-C.; Liang C.-W.; Hsu H.-H.; Jeng Y.-M. | Human Pathology | 26 | 33 | |
2016 | Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma | Chen H.-A.; Kuo T.-C.; Tseng C.-F.; Ma J.-T.; Yang S.-T.; Yen C.-J.; CHING-YAO YANG ; Sung S.-Y.; Su J.-L. | Hepatology | 53 | 65 | |
2009 | Application of rituximab to hepatitis C-positive, ABO-incompatible renal transplantation | Tsai M.-K.; CHING-YAO YANG ; Wu M.-S.; Lee P.-H. | International Journal of Artificial Organs | 2 | 2 | |
2011 | Arsenic and diabetes: Current perspectives | Huang C.F.; Chen Y.W.; CHING-YAO YANG ; Tsai K.S.; Yang R.S.; Liu S.H. | Kaohsiung Journal of Medical Sciences | 36 | 38 | |
2015 | Arsenic exposure and glucose intolerance/insulin resistance in estrogen-deficient female mice | Huang C.-F.; CHING-YAO YANG ; Chan D.-C.; Wang C.-C.; Huang K.-H.; Wu C.-C.; Tsai K.-S.; Yang R.-S.; Liu S.-H. | Environmental Health Perspectives | 35 | 40 | |
2011 | Arsenic induces pancreatic β-cell apoptosis via the oxidative stress-regulated mitochondria-dependent and endoplasmic reticulum stress-triggered signaling pathways | Lu T.-H.; Su C.-C.; Chen Y.-W.; CHING-YAO YANG ; Wu C.-C.; Hung D.-Z.; Chen C.-H.; Cheng P.-W.; Liu S.-H.; Huang C.-F. | Toxicology Letters | 122 | 129 | |
2014 | Arsenic induces reactive oxygen species-caused neuronal cell apoptosis through JNK/ERK-mediated mitochondria-dependent and GRP 78/CHOP-regulated pathways | Lu T.-H.; Tseng T.-J.; Su C.-C.; Tang F.-C.; Yen C.-C.; Liu Y.-Y.; CHING-YAO YANG ; Wu C.-C.; Chen K.-L.; Hung D.-Z.; Chen Y.-W. | Toxicology Letters | 116 | 123 | |
2015 | B cells and immunoglobulin in ABO-incompatible renal transplant patients receiving rituximab and double filtration plasmapheresis | Tsai M.-K.; Wu M.-S.; CHING-YAO YANG ; Lee C.-Y.; Yeh C.-C.; Hu R.-H.; Lee P.-H.; Lai H.-S. | Journal of the Formosan Medical Association | 5 | 6 | |
2019 | Cadmium exposure induces pancreatic β-cell death via a Ca2+-triggered JNK/CHOP-related apoptotic signaling pathway | Huang, Cheng-Chin; Kuo, Chun-Ying; CHING-YAO YANG ; Liu, Jui-Ming; Hsu, Ren-Jun; Lee, Kuan-I; Su, Chin-Chuan; Wu, Chin-Ching; Lin, Ching-Ting; Liu, Shing-Hwa; Huang, Chun-Fa | Toxicology | | 17 | |
2015 | Change of both endocrine and exocrine insufficiencies after acute pancreatitis in non-diabetic patients | Ho T.-W.; Wu J.-M.; Kuo T.-C.; CHING-YAO YANG ; Lai H.-S.; Hsieh S.-H.; Lai F.; Tien Y.-W. | Medicine (United States) | 19 | 25 | |
2018 | Changes in glucose metabolism after distal pancreatectomy: a nationwide database study | Wu, Jin-Ming; Ho, Te-Wei; CHING-YAO YANG ; Lee, Po-Huang; Tien, Yu-Wen | Oncotarget | | 0 | |
2020 | Claudin-18 as a Marker for Identifying the Stomach and Pancreatobiliary Tract as the Primary Sites of Metastatic Adenocarcinoma | Li W.-T.; Jeng Y.-M.; CHING-YAO YANG | American Journal of Surgical Pathology | 5 | 6 | |
2016 | Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma | Chang M.-C.; Chang Y.-T.; Chen J.-Y.; Jeng Y.-M.; CHING-YAO YANG ; Tien Y.-W.; Yang S.-H.; Chen H.-L.; Liang T.-Y.; Wang C.-F.; Lee E.Y.H.P.; Chang Y.-C.; Lee W.-H. | Clinical Chemistry | 47 | 59 | |
2014 | Comparison and validation of International Consensus Diagnostic Criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a Taiwanese cohort | Chang M.-C.; Liang P.-C.; Jan I.-S.; CHING-YAO YANG ; Tien Y.-W.; Wei S.-C.; Wong J.-M.; Chang Y.-T. | BMJ Open | 5 | 5 | |
2015 | Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas | Liau J.-Y.; Lee J.-C.; Tsai J.-H.; CHING-YAO YANG ; Liu T.-L.; Ke Z.-L.; Hsu H.-H.; Jeng Y.-M. | Modern Pathology | 31 | 38 | |
2005 | Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer | Lin B.-R.; Chang C.-C.; Che T.-F.; Chen S.-T.; Chen R.J.-C.; CHING-YAO YANG ; Jeng Y.-M.; Liang J.-T.; Lee P.-H.; Chang K.-J.; Chau Y.-P.; Kuo M.-L. | Gastroenterology | 100 | 103 | |